Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from C-Rad AB Class B ( ($SE:CRAD.B) ).
C-RAD has entered a strategic agreement with Ramsay Santé, a leading private healthcare provider in Europe, to deliver its Surface Guided Radiation Therapy (SGRT) solutions to two hospitals in France. This collaboration, valued at 8.5 MSEK, marks a significant milestone for C-RAD in the French market, enhancing Ramsay Santé’s oncology network and setting a new standard in radiation oncology across France.
More about C-Rad AB Class B
C-RAD develops surface-guided imaging solutions for radiation therapy, focusing on delivering highly accurate dose delivery to tumors while protecting healthy tissue. The company utilizes high-speed 3D cameras and augmented reality to enhance patient setup and monitor motion during treatment, ensuring safety and comfort. C-RAD is listed on NASDAQ Stockholm.
Average Trading Volume: 51,080
Current Market Cap: SEK1.11B
Learn more about CRAD.B stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue